EU Project Parkinson Approved
The goal of the project is to establish an individualized patients’ medication with respect to the actual symptoms. A sensor based gait pattern monitoring of Parkinson patients allows evidence based decision making with regards to the dosage of medicine to minimize severe side effects caused by medication.
The new project will allow people with Parkinson’s to be followed by a multidisciplinary team with a set of unobtrusive, simple-in-use, co-operative, mobile devices such as the OpenGo sensor insole, that will be used for symptoms monitoring and collection of adherence data.
The study is coordinated by the Jožef Stefan Institute in Ljubljana while the technical aspects are supervised by the Biomedical Engineering Department of the University of Ioannina. The clinical partners are the IRCCS San Camillo Hospital of Venice, IRCCS Santa Lucia in Rome, the Neurology Clinic of the University Ioannina (Greece) and the rehabilitation Centre University of Ljubljana (Slovenia).
Lasting three years, the project has received 4.3 million euros funding from the European Union within the European framework program for research and innovation Horizon 2020.
After the definition of user needs under the coordination of the psychology unit of the University of Surrey, the project will involve in the pilot phase, 30 patients and, at the end of 2016, it will become one of the largest multi-center studies involving a total of 230 patients across four European centers. During the stages of advancement, updates will be provided with live demonstrations of the achievements, to all the countries involved utilizing the power of the web. Furthermore, the technologies that will result will be made available to all. The project partners are pleased to have the support of the European Parkinson Disease Association (EPDA) who will help in the trans-national dissemination of results.